Clicky

Grifols Sa Barcelona(GIFLF)

Description: Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use, including the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. It offers plasma products, such as intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products comprising analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.


Keywords: Pharmaceutical Infectious Diseases Healthcare Providers Ibex 35 Nutrition Products Hematology Economy Of Spain Biological Products Nose Hemophilia Fluids In Vitro Diagnostics Diagnostics Products Bumi Party Distributors Infusion Solutions Enteral Nutrition Grifols Plasma Products Thrombin Group Purchasing Organization Hospital Immunohematology Services In Vitro Diagnostics Products Parenteral Solutions Blood Bank Laboratories

Home Page: www.grifols.com

Avinguda de la Generalitat, 152
Barcelona, 08174
Spain
Phone: 34 93 571 02 21


Officers

Name Title
Mr. Steven Francis Mayer J.D. Exec. Chairman
Mr. Raimon Grifols Roura Co-CEO & Exec. Director
Mr. Víctor Grifols Deu Co-CEO & Exec. Director
Mr. Alfredo Arroyo Guerra CFO & VP
Mrs. Eva Bastida Tubau Corp. VP and Director of Scientific & Medical Affairs
Ms. Nuria Pascual Lapeña VP of Corp. Treasury, Risk Management Investor Relation & Sustainability Officer
Mr. David Ian Bell Gen. Counsel & Chief Corp. Devel. Officer
Mr. Mateo Florencio Borrás Humbert Corp. VP & Chief HR Officer
Ms. Maria Teresa-Rioné Llano Chief Communications Officer
Ms. Montserrat Gaja Llamas Chief HR Officer

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 17.2712
Trailing PE: 112.6401
Price-to-Book MRQ: 1.0383
Price-to-Sales TTM: 1.3414
IPO Date:
Fiscal Year End: December
Full Time Employees: 27584
Back to stocks